医薬品開発受託機関・CRO向け臨床試験情報
質の高い情報とデータベースの提供を通じて、CROのビジネス獲得と医薬品開発サービスの強化を支援します。臨床試験の計画および実施に際して、よりデータに基づいた意思決定を行えるようになります。
質の高い情報とデータベースの提供を通じて、CROのビジネス獲得と医薬品開発サービスの強化を支援します。臨床試験の計画および実施に際して、よりデータに基づいた意思決定を行えるようになります。
.jpg?h=415&w=558&la=ja-JP&hash=DD0327971FAA2B3A2DB9E9784666A25C0999DE0A)
インフォーマ・ファーマインテリジェンスは世界のCRO（医薬品開発受託機関）上位10社と医薬品企業上位50社を含む3,000社以上のお客様にサービスを提供しています。
リード探索からターゲット設定、提案準備、実現可能性の評価、スポンサーとのミーティング、臨床試験の実施まで。より多くのビジネスを勝ち取り、臨床試験の最適化を手助けする情報を提供します。
Virtually gather feedback from experts, ignite awareness of your clinical studies, and recruit experienced investigators.
Virtually gather feedback from experts, ignite awareness of your clinical studies, and recruit experienced investigators.
Depression affects approximately 1 in 6 Americans, with 10 – 30% of depression patients becoming treatment-resistant. Find out what the pipeline looks like for depression and what the emerging strategies in this area are. This data-packed whitepaper from Informa Pharma Intelligence can now be downloaded – free.
Join our panel of experts as they discuss the impact of COVID-19 on clinical trials, the new normal and future pathways to get ahead. Get the latest insights and status on recent clinical trials, the emergence of virtual trials, and what you need to know for success.
Citeline
Listen to our podcast “The Future of Clinical Trials From the Investigator Perspective” from earlier this year and register for our upcoming webinar to learn new developments
Topic Clinical Trials Coronavirus
See how Citeline Engage can help you at every stage of your clinical trial
Pink Sheet: 世界の薬事規制と承認審査に関するニュース
Rising costs, patient recruitment issues, shifting regulations, and more are making bringing new drugs to market more difficult than ever. Explore changes in clinical trial design being adopted in response to these challenges with reporting from Pink Sheet.
With opioid abuse and deaths in the US at an all-time high, the journey to battle the opioid epidemic continues – keeping drug companies and the FDA working hard to come up with effective alternatives for pain.
Sitetrove: 治験責任医師と治験施設情報のデータベース, Trialtrove: 医療用医薬品の臨床試験情報デー...
Citeline is the industry’s most comprehensive, reliable and up-to-date global clinical trial intelligence suite, designed to help you save time and money by enrolling patients faster. Our team of more than 250 industry experts transform data into knowledge, integrating robust drug, trial, investigator, and site intelligence.
Twenty years ago, there was a shift in pain management, and it became more common to prescribe opioids for chronic pain.
Pharmaprojects: 医薬品開発パイプラインのデータベース
Take the analysis from the Informa Pharma Intelligence R&D Annual Review 2019 further with the Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018. This essential whitepaper uses critical data from Pharmaprojects to examine the new entities that were successfully launched to market last year.
Citeline
While AIDS therapy was once confined to palliative care, clinical progress in the wake of the landmark 1987 approval of zidovudine has seen HIV demoted to a chronic but manageable infection. Following the initial fledgling steps and missteps, the mid-1990s saw the introduction of the now-familiar three-drug combination regimens that raised expectations for a pharmaceutical solution to the epidemic.
Topic Infectious diseases
Trialtrove: 医療用医薬品の臨床試験情報データベース
Explore the current and future outlook for rheumatoid arthritis (RA) treatments. Such treatments remain ineffective for the 33% of RA sufferers who are or become unresponsive to treatment, resulting in a high interest in RA drug development to address this unmet need in the marketplace.
Citeline, Scrip: 世界の医療用医薬品＆製薬産業に関するニュース, Biomedtracker: 開発中医...
Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting. Let our experts present their top picks from the thousands of abstracts being presented at ASCO.
Topic Clinical trials
Citeline
Using exclusive data from Citeline’s Trialtrove, part of the Informa Pharma Intelligence suite of tools, our analysts will go beyond the numbers and dig into the granular details and their implications.
Topic clinical-trials
We've made the valuable and trustworthy content of Sitetrove and Trialtrove even better via the enhanced features of the new platform.
Citeline
The standard of care treatment for multiple sclerosis involves immunomodulatory therapy to relieve and/or modify symptoms; the vast majority of these are large biologic molecules and are administered via injection.
Topic multiple-sclerosis
製品説明＆デモお申込
専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。
＊一部のサービスでは無料トライアルをご利用になれません。
お問い合わせ先
新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。お問合せの際は下記メールアドレスまたは各営業スタッフまでご連絡下さいますようご協力をお願い申し上げます。
インフォーマインテリジェンス合同会社
ファーマインテリジェンス
inquiry.jp@informa.com
＊Omdia（ICT産業の情報）に関するお問い合わせはこちら
Contact_OmdiaJapan@omdia.com
レポートストア
オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。
お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。
